Amarin Corp Plc (AMRN)

[CaptBeer]

$AMRN There’s been a lot of discussion regarding case law involving “skinny labeling” and generics tightrope walking of “induced” or “direct infringement”. In our case it appears that we may have a good case for both induced and direct intent to infringe our REDUCE-IT label and patents.

Attached here is Slide # 12 from Hikma’s Investor Presentation at J.P. Morgan’s 38th Annual Healthcare Conference held in January 2020. This slide clearly reveals Hikma’s intent to directly infringe Amarin’s REDUCE-IT label. Their $752 million U.S. market value far exceeds Amarin’s own 2020 projection of $650-700 million dollars!